Celyad Oncology SA
CLYYF
$0.65
-$0.03-4.41%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -43.83% | -36.81% | 22.86% | 24.30% | -41.79% |
| Total Receivables | -69.44% | -65.62% | -49.08% | -48.47% | 128.38% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -29.68% | -20.88% | 229.40% | 233.30% | 95.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -45.24% | -38.40% | -83.84% | -83.65% | -82.46% |
| Total Current Assets | -45.13% | -38.27% | 10.49% | 11.79% | -22.41% |
|
|
|||||
| Total Current Assets | -45.13% | -38.27% | 10.49% | 11.79% | -22.41% |
| Net Property, Plant & Equipment | -23.59% | -14.03% | 93.16% | 95.44% | 512.60% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -55.18% | -49.41% | -90.54% | -90.42% | -89.10% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -45.88% | -39.11% | -27.43% | -26.57% | -17.70% |
| Total Assets | -42.89% | -35.75% | 3.53% | 4.75% | -14.59% |
|
|
|||||
| Total Accounts Payable | -7.09% | 4.53% | -69.50% | -69.14% | -72.95% |
| Total Accrued Expenses | -16.34% | -5.89% | -53.25% | -52.70% | -63.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.73% | -4.06% | -17.77% | -16.82% | 17.76% |
| Total Finance Division Other Current Liabilities | -7.15% | 4.46% | -52.58% | -52.02% | -74.15% |
| Total Other Current Liabilities | -7.15% | 4.46% | -52.58% | -52.02% | -74.15% |
| Total Current Liabilities | -9.08% | 2.28% | -61.08% | -60.62% | -70.91% |
|
|
|||||
| Total Current Liabilities | -9.08% | 2.28% | -61.08% | -60.62% | -70.91% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -20.77% | -10.86% | 133.19% | 135.92% | 690.64% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -11.46% | -0.39% | 31.76% | 33.30% | 30.89% |
| Total Liabilities | -11.60% | -0.55% | -15.73% | -14.74% | -32.98% |
|
|
|||||
| Common Stock & APIC | -76.64% | -73.72% | -90.50% | -90.39% | -59.86% |
| Retained Earnings | 4.81% | -7.09% | -0.29% | -1.47% | -5.92% |
| Treasury Stock & Other | 0.66% | 13.24% | 29.67% | 31.19% | 27.37% |
| Total Common Equity | -92.41% | -91.46% | 214.48% | 218.17% | 51.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -92.41% | -91.46% | 214.48% | 218.17% | 51.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -92.41% | -91.46% | 214.48% | 218.17% | 51.03% |
|
|
|||||